Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/27/2014US20140088160 Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereof
03/27/2014US20140088155 d-Methadone for the Treatment of Psychiatric Symptoms
03/27/2014US20140088148 Small molecule inhibitors of xbp1 splicing
03/27/2014US20140088147 Method of inhibiting mutant c-kit
03/27/2014US20140088145 Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntington's disease
03/27/2014US20140088144 Inhibiting microbial infections
03/27/2014US20140088143 Method of Inhibiting Constitutively Active Phosphorylated FLT3 Kinase
03/27/2014US20140088140 Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular huntington's disease
03/27/2014US20140088139 Compositions and methods of use of an inappetance-controlling compound
03/27/2014US20140088137 Composition Comprising Hepatic Therapeutic Active for Treating Liver Diseases, Certain Cancers and Liver Health Maintenance
03/27/2014US20140088136 Composition Comprising Hepatic Therapeutic Active for Treating Liver Diseases, Certain Cancers and Liver Health Maintenance
03/27/2014US20140088135 Immunosuppressive macrolide powder for oral suspension
03/27/2014US20140088134 Pharmaceutical composition for topical application
03/27/2014US20140088131 Implantable Polymeric Device for Sustained Release of Buprenorphine
03/27/2014US20140088129 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
03/27/2014US20140088128 Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
03/27/2014US20140088127 Novel process to prepare pioglitazone via several novel intermediates
03/27/2014US20140088126 Rosuvastatin Enantiomer Compounds
03/27/2014US20140088123 Treatment of lung cancer
03/27/2014US20140088120 Modulators of Androgen Synthesis
03/27/2014US20140088119 Muscarinic Agonists as Enhancers of Working Memory and Cognitive Flexibility
03/27/2014US20140088117 Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/27/2014US20140088110 Fused bicyclic imidazoles
03/27/2014US20140088108 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitiors
03/27/2014US20140088107 Ophthalmic preparation comprising a pgf2alpha analogue
03/27/2014US20140088106 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/27/2014US20140088105 Cyclohexyl Amide Derivatives and Their Use as CRF-1 Receptor Antagonists
03/27/2014US20140088102 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
03/27/2014US20140088097 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
03/27/2014US20140088090 6,7-DIHYDRO-[1,3,4]THIADIAZOLO-[3,2-a][1,3]DIAZEPIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS HYPNOTIC OR ANESTHETIC AGENT AND METHOD FOR THEIR PREPARATION
03/27/2014US20140088089 Cytotoxic benzodiazepine derivatives and methods of preparation
03/27/2014US20140088084 Oxazine derivatives and their use in the treatment of neurological disorders
03/27/2014US20140088083 Use of memantine (namenda) to treat autism, compulsivity, and impulsivity
03/27/2014US20140088082 Inhibitors of the plasmodial surface anion channel as antimalarials
03/27/2014US20140088081 Amino-Heterocyclic Compounds
03/27/2014US20140088077 Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
03/27/2014US20140088074 Fluorinated arylalkylaminocarboxamide derivatives
03/27/2014US20140088073 Methods for determining whether a patient should be administered a drug that inhibits cholesterol absorption
03/27/2014US20140088071 sGC STIMULATORS
03/27/2014US20140088070 Nitrogen containing compounds and their use
03/27/2014US20140088069 Novel antibacterial combination therapy
03/27/2014US20140088068 1,6-Diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
03/27/2014US20140088067 Tazobactam arginine compositions
03/27/2014US20140088065 Composition and method for affecting obesity and related conditions
03/27/2014US20140088062 Compositions comprising fusidic acid and packages therefor
03/27/2014US20140088061 Pharmaceutical composition
03/27/2014US20140088059 Compositions and Methods for Localized Drug Delivery through Mammary Papillae
03/27/2014US20140088058 Selective cns delivery of mifepristone (ru486) to modulate the timing of the spontaneous lh surge during follicular stimulation cycles
03/27/2014US20140088057 Methods of treating pre-term labor
03/27/2014US20140088056 Cardiac glycosides are potent inhibitors of interferon-beta gene expression
03/27/2014US20140088054 Method For Treating Erectile Dysfunction
03/27/2014US20140088053 INHIBITORS OF 17Beta-HSD1, 17Beta-HSD3 AND 17Beta-HSD10
03/27/2014US20140088052 Chalcone derivatives as nrf2 activators
03/27/2014US20140088051 Natural combination hormone replacement formulations and therapies
03/27/2014US20140088050 Use of androgen for disease treatment
03/27/2014US20140088047 Use of long chain polyunsaturated fatty acid derivatives to treat sickle cell disease
03/27/2014US20140088045 Product comprising a nicotine-containing material and an anti-cancer agent
03/27/2014US20140088044 Product comprising a nicotine-containing material and an anti-cancer agent
03/27/2014US20140088043 Omega-3 compositions
03/27/2014US20140088042 Proteasome Inhibitors And Methods Of Using The Same
03/27/2014US20140088039 Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol
03/27/2014US20140088038 Compositions and methods for stabilized polysaccharide formulations
03/27/2014US20140088036 Polyphosphate and pyrophosphate derivative of saccharides
03/27/2014US20140088035 Treating schizophrenia
03/27/2014US20140088034 NITRIC OXIDE/cGMP PATHWAY INHIBITION OF VLA-4 RELATED CELL ADHESION
03/27/2014US20140088032 Treatment of mastitis
03/27/2014US20140088027 Pharmaceutical composition comprising an sglt2 inhibitor and a ppar- gamma agonist and uses thereof
03/27/2014US20140088026 Lyophilization of synthetic liposomal pulmonary surfactant
03/27/2014US20140088025 Lyophilization of synthetic liposomal pulmonary surfactant
03/27/2014US20140088023 sGCalpha1 Inhibiting Compositions, and Methods of Treatment of Cancers Therewith
03/27/2014US20140088011 Softgel of NLKJ for treating prostate diseases
03/27/2014US20140088003 Polymer-based sustained release device
03/27/2014US20140088002 Compositions and methods for treatment of diabetes
03/27/2014US20140087998 Use of pacap for the treatment viral infections in aquatic organisms
03/27/2014US20140087996 Pharmaceutical composition, methods for treating and uses thereof
03/27/2014US20140087992 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
03/27/2014US20140087943 Pesticidal Active Mixtures Comprising Isoxazoline Compounds I
03/27/2014US20140087384 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
03/27/2014US20140087059 Pharmaceutical composition and process for montelukast tablets
03/27/2014US20140087009 Composition of Beta-Glucan and Ashwagandha
03/27/2014US20140087007 Bowel cleansing preparations
03/27/2014US20140087005 Modulators of hsp70/dnak function and methods of use thereof
03/27/2014US20140087000 Method and System for Treatment of Biological Tissue
03/27/2014US20140086998 Compositions And Methods Relating To Solenopsins And Their Uses In Treating Neurological Disorders And Enhancing Physical Performance
03/27/2014US20140086996 Water-soluble drug carrier and process for producing the same
03/27/2014US20140086995 Polymer microsphere compositions for localized delivery of therapeutic agents
03/27/2014US20140086990 Sustained release small molecule drug formulation
03/27/2014US20140086987 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
03/27/2014US20140086986 Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
03/27/2014US20140086985 Composition useful for the treatment of lipid metabolism disorders
03/27/2014US20140086984 Pharmaceutical use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and pharmaceutically acceptable salt or derivative thereof
03/27/2014US20140086983 Methods for the preparation of liposomes comprising drugs
03/27/2014US20140086980 Treatment of erectile dysfunction and other indications
03/27/2014US20140086978 Transdermal Therapeutic System Provided With Improved Long-Term Carrying Comfort
03/27/2014US20140086977 Tight junctions modulators
03/27/2014US20140086975 Hydrogel formulation for dermal and ocular delivery
03/27/2014US20140086973 Pharmaceutical preparation
03/27/2014US20140086972 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2014US20140086961 Use of cyclodextrins in diets, water or vaccine adjuvants to boost the immune system of fish
03/27/2014US20140086960 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
1 ... 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 ... 7860